News
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...
In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
A former Pfizer Inc. scientist denied an allegation made by House Republicans that he conspired to delay the release of Covid ...
Zohran Mamdani told a group of top business leaders in New York City on Tuesday that he would discourage the use of the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
1d
Zacks Investment Research on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...
Australia ‘undervalues’ the products of drug companies, Pfizer has told the Productivity Commission, echoing US lobbyists ...
Pfizer Inc. (NYSE:PFE) is one of the Best Large Cap Value Stocks to Invest In. Morningstar reduced its moat rating for the ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
2d
Zacks.com on MSNPfizer (PFE) Stock Sinks As Market Gains: Here's WhyPfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior day's close.
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
13don MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results